Centessa Pharmaceuticals plc American Depositary Shares
Symbol: CNTA (NASDAQ)
21.82
▼ (-3.77%) -0.855
Company Description:
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
Key Stats
- Today's Open: $22.49
- Today's High: $22.84
- Today's Low: $21.487
- Today's Volume: 1.30M
- Yesterday Close: $22.67
- Yesterday High: $23.24
- Yesterday Low: $22.52
- Yesterday Volume: 1.28M
- Last Min Volume: 100
- Last Min High: $21.815
- Last Min Low: $21.815
- Last Min VWAP: $21.815
Company Profile
- Name: Centessa Pharmaceuticals plc American Depositary Shares
- Website: https://www.centessa.com
- Listed Date: 2021-05-28
- Location: ALTRINCHAM, CHESHIRE, X0
- Market Status: Active
- CIK Number: 0001847903
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $3.04B
- Round Lot: 100
- Outstanding Shares: 134.07M
- Asset Type: ADRC
RECENT FILINGS FOR CNTA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-11 | 4 | View |
| 2025-09-11 | 4 | View |
| 2025-09-11 | 4 | View |
| 2025-09-10 | 144 | View |
| 2025-09-10 | 144 | View |
| 2025-09-09 | 144 | View |
| 2025-09-09 | 144 | View |
| 2025-09-09 | 144 | View |
| 2025-08-15 | 4 | View |
| 2025-08-15 | 144 | View |
| 2025-08-12 | SCHEDULE 13G/A | View |
| 2025-08-12 | 10-Q | View |
| 2025-08-12 | 8-K | View |
| 2025-08-01 | 4 | View |
| 2025-07-30 | 4 | View |
| 2025-07-29 | 144 | View |
| 2025-07-25 | 4 | View |
| 2025-07-25 | 144 | View |
| 2025-07-21 | 4 | View |
| 2025-07-21 | 144 | View |
Latest News on CNTA